Hepatitis B Vaccine Predialysis/Dialysis Study (V232-060)

Clinical trial NCT00440297 · COMPLETED

Trial details

NCT number: NCT00440297
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Hepatitis B Virus Infection

Start date: 2006-12-01
Primary completion: 2008-05-01
Enrollment: 277

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.